source
- BMS CAR-T therapy arlo-cel meets primary endpoint in pivotal multiple myeloma trialBristol Myers Squibb reported that its GPRC5D-directed CAR-T cell therapy, arlo-cel, achieved the primary endpoint in the pivotal Quintessential trial for multiple myeloma. The study enrolled pati…
- Rural hospitals seek partnership deals as Trump Medicaid cuts threaten financial stabilityRural health systems are looking for mergers or partnership agreements to stay afloat as the Trump administration prepares unprecedented cuts to Medicaid funding. The anticipated reductions are pr…